Wai Chun Bio-Technology Limited (HKG:0660)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.231
-0.002 (-0.86%)
Mar 10, 2026, 2:01 PM HKT

Wai Chun Bio-Technology Revenue

Wai Chun Bio-Technology had revenue of 352.15M HKD in the half year ending December 31, 2025, with 85.02% growth. This brings the company's revenue in the last twelve months to 568.26M, up 66.75% year-over-year. In the fiscal year ending June 30, 2025, Wai Chun Bio-Technology had annual revenue of 377.17M with 1.92% growth.

Revenue (ttm)
568.26M
Revenue Growth
+66.75%
P/S Ratio
0.08
Revenue / Employee
9.47M
Employees
61
Market Cap
42.83M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 2025377.17M7.10M1.92%
Jun 30, 2024370.07M-403.59M-52.17%
Jun 30, 2023773.65M102.20M15.22%
Jun 30, 2022671.46M176.08M35.54%
Dec 31, 2021495.38M-72.18M-12.72%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition